Which drug should be used as a first option for acute relief in asthma management?

Salbutamol is recognized as the first-line option for acute relief in asthma management due to its rapid onset of action and effectiveness as a short-acting beta-agonist (SABA). It works by relaxing bronchial smooth muscle, leading to dilation of the airways, which helps alleviate acute bronchoconstriction experienced during an asthma attack. This immediate bronchodilator effect makes it particularly useful in emergency situations where quick relief of symptoms is necessary.

While other options such as Montelukast, Salmeterol, and Fluticasone play important roles in long-term asthma management, they do not serve as primary treatments for acute exacerbations. Montelukast is a leukotriene receptor antagonist that is typically used for maintenance therapy rather than immediate symptom relief. Salmeterol, a long-acting beta-agonist (LABA), provides sustained bronchodilation but is not suitable for acute asthma symptoms because it takes longer to act. Fluticasone is an inhaled corticosteroid that helps reduce inflammation over time but does not offer the rapid bronchodilation needed during an asthma attack. Therefore, Salbutamol is the preferred choice for immediate treatment in acute scenarios.